Tassia Cristina Decimoni

1PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 26, 2023
Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective.

Nishit Dhanji, Tassia Cristina Decimoni, Matthew T D Dyer

Pageof 1

Frequent Collaborators

1 joint publications

Jessica R May

1 joint publications

Svenja Petersohn